Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form.
Tabarsi P, Vahidi H, Saffaei A, Hashemian SMR, Jammati H, Daraei B, Mahboubi A, Kobarfard F, Marjani M, Moniri A, Abtahian Z, Abedini A, Eslaminejad A, Heshmatnia J, Mirenayat MS, Fakharian A, Seifi S, Sadeghi M, Dastan A, Haseli S, Nadji SA, Eskandari R, Yousefian S, Varahram M, Zali A, Velayati AA, Dastan F.
Tabarsi P, et al. Among authors: fakharian a.
Iran J Pharm Res. 2021 Fall;20(4):1-8. doi: 10.22037/ijpr.2021.115510.15401.
Iran J Pharm Res. 2021.
PMID: 35194422
Free PMC article.